Kaliberova LN - Search Results

1

COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.

Prima V, Kaliberova LN, Kaliberov S, Curiel DT, Kusmartsev S. Prima V, et al. Among authors: kaliberova ln. Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1117-1122. doi: 10.1073/pnas.1612920114. Epub 2017 Jan 17. Proc Natl Acad Sci U S A. 2017. PMID: 28096371 Free PMC article.

2

Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.

Eruslanov E, Kaliberov S, Daurkin I, Kaliberova L, Buchsbaum D, Vieweg J, Kusmartsev S. Eruslanov E, et al. J Immunol. 2009 Jun 15;182(12):7548-57. doi: 10.4049/jimmunol.0802358. J Immunol. 2009. PMID: 19494278

3

Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice.

Lu ZH, Kaliberov S, Sohn RE, Kaliberova L, Curiel DT, Arbeit JM. Lu ZH, et al. PLoS One. 2013 Dec 23;8(12):e83933. doi: 10.1371/journal.pone.0083933. eCollection 2013. PLoS One. 2013. PMID: 24376772 Free PMC article.

4

The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting.

Lu ZH, Kaliberov S, Zhang J, Muz B, Azab AK, Sohn RE, Kaliberova L, Du Y, Curiel DT, Arbeit JM. Lu ZH, et al. Lab Invest. 2014 Aug;94(8):881-92. doi: 10.1038/labinvest.2014.78. Epub 2014 Jun 23. Lab Invest. 2014. PMID: 24955893 Free PMC article.

5

A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector.

Lu ZH, Kaliberov S, Sohn RE, Kaliberova L, Du Y, Prior JL, Leib DJ, Chauchereau A, Sehn JK, Curiel DT, Arbeit JM. Lu ZH, et al. Oncotarget. 2017 Feb 14;8(7):12272-12289. doi: 10.18632/oncotarget.14699. Oncotarget. 2017. PMID: 28103576 Free PMC article.

6

Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas.

Kaliberov SA, Kaliberova LN, Buchsbaum DJ. Kaliberov SA, et al. Among authors: kaliberova ln. Gene Ther. 2005 Mar;12(5):407-17. doi: 10.1038/sj.gt.3302432. Gene Ther. 2005. PMID: 15616600

7

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus.

Kaliberov SA, Kaliberova LN, Buchsbaum DJ, Curiel DT. Kaliberov SA, et al. Among authors: kaliberova ln. Cancer Gene Ther. 2014 Jul;21(7):264-74. doi: 10.1038/cgt.2014.26. Epub 2014 Jun 6. Cancer Gene Ther. 2014. PMID: 24903014 Free PMC article.

8

Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.

Kaliberova LN, Kusmartsev SA, Krendelchtchikova V, Stockard CR, Grizzle WE, Buchsbaum DJ, Kaliberov SA. Kaliberova LN, et al. Mol Cancer Ther. 2009 Nov;8(11):3130-9. doi: 10.1158/1535-7163.MCT-09-0270. Epub 2009 Nov 3. Mol Cancer Ther. 2009. PMID: 19887544

9

Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.

Kaliberov SA, Kaliberova LN, Hong Lu Z, Preuss MA, Barnes JA, Stockard CR, Grizzle WE, Arbeit JM, Curiel DT. Kaliberov SA, et al. Among authors: kaliberova ln. Virology. 2013 Dec;447(1-2):312-25. doi: 10.1016/j.virol.2013.09.020. Epub 2013 Oct 15. Virology. 2013. PMID: 24210128 Free PMC article.

10

Adenoviral targeting using genetically incorporated camelid single variable domains.

Kaliberov SA, Kaliberova LN, Buggio M, Tremblay JM, Shoemaker CB, Curiel DT. Kaliberov SA, et al. Among authors: kaliberova ln. Lab Invest. 2014 Aug;94(8):893-905. doi: 10.1038/labinvest.2014.82. Epub 2014 Jun 16. Lab Invest. 2014. PMID: 24933423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters